Those with two copies of the vav-Myc transgene (“Mychi”) developed pure T-cell lymphomas, whereas those with only a single copy of the transgene (“Myclo”) developed both lymphoid and myeloid neoplasms [295,296]. This evidence concerns the gene MYC and T-cell non-Hodgkin lymphoma.